Using flow cytometric analyses, we detected no EOMES expression in CLL cells, whereas the average percentage of EOMES-positive CD8+ T cells in PB from CLL patients was 61.5 ± 8.39% (Supplementary Fig. 1A–C). Here, CD8A is linked to B-cell chronic lymphocytic leukemia.